These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 19407010
1. Effect of intravitreal injection of high-dose bevacizumab in monkey eyes. Sakurai K, Akiyama H, Shimoda Y, Yoshida I, Kurabayashi M, Kishi S. Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4905-16. PubMed ID: 19407010 [Abstract] [Full Text] [Related]
2. Preclinical safety evaluation of intravitreal injection of full-length humanized vascular endothelial growth factor antibody in rabbit eyes. Inan UU, Avci B, Kusbeci T, Kaderli B, Avci R, Temel SG. Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1773-81. PubMed ID: 17389511 [Abstract] [Full Text] [Related]
4. Angiographic changes in iris and iridocorneal angle neovascularization after intravitreal bevacizumab injection. Ishibashi S, Tawara A, Sohma R, Kubota T, Toh N. Arch Ophthalmol; 2010 Dec; 128(12):1539-45. PubMed ID: 21149776 [Abstract] [Full Text] [Related]
5. Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography. Hatta Y, Ishikawa K, Nishihara H, Ozawa S, Ito Y, Terasaki H. Retina; 2010 Mar; 30(3):495-502. PubMed ID: 19996828 [Abstract] [Full Text] [Related]
6. Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization in age-related macular degeneration. Furino C, Boscia F, Recchimurzo N, Besozzi G, Cardascia N, Sborgia L, Niro A, Sborgia C. Acta Ophthalmol; 2009 Jun; 87(4):404-7. PubMed ID: 18782335 [Abstract] [Full Text] [Related]
11. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema. Kook D, Wolf A, Kreutzer T, Neubauer A, Strauss R, Ulbig M, Kampik A, Haritoglou C. Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710 [Abstract] [Full Text] [Related]
13. Bevacizumab (avastin) does not harm retinal function after intravitreal injection as shown by electroretinography in adult mice. Heiduschka P, Julien S, Hofmeister S, Bartz-Schmidt KU, Schraermeyer U. Retina; 2008 Jan; 28(1):46-55. PubMed ID: 18185137 [Abstract] [Full Text] [Related]
15. Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections. Melamud A, Stinnett S, Fekrat S. Am J Ophthalmol; 2008 Jul; 146(1):91-5. PubMed ID: 18455144 [Abstract] [Full Text] [Related]
18. Clinical and histological findings after intravitreal injection of bevacizumab (Avastin) in a porcine model of choroidal neovascularization. Lassota N, Prause JU, Scherfig E, Kiilgaard JF, la Cour M. Acta Ophthalmol; 2010 May; 88(3):300-8. PubMed ID: 19416113 [Abstract] [Full Text] [Related]